For Prostate Cancer, Referral-Based Exercise Program Beneficial

Share this content:
For men with prostate cancer, clinician referral to and participation in an exercise program has a positive impact on mental health.
For men with prostate cancer, clinician referral to and participation in an exercise program has a positive impact on mental health.

For men with prostate cancer, clinician referral to and participation in an exercise program has a positive impact on mental health, according to a study published in Cancer.

Patricia M. Livingston, Ph.D., from Deakin University in Burwood, Australia, and colleagues conducted a multicenter cluster randomized controlled trial involving 15 clinicians.

Eight clinicians were randomized to refer eligible participants with prostate cancer to a 12-week exercise program (two supervised gym sessions and one home-based session; 54 patients) and seven were randomized to follow usual care (93 patients).

The researchers identified a significant intervention effect for vigorous-intensity exercise (effect size: Cohen's d, 0.46; P = 0.01), but not for combined moderate and vigorous exercise levels (effect size: d, 0.08: P = 0.48). 

Meeting exercise guidelines (≥150 minutes/week) was also associated with significant intervention effects (odds ratio, 3.9); positive intervention effects were seen for cognitive functioning (effect size: d, 0.34; P = 0.06) and depression symptoms (effect size: d −0.35; P = 0.06) in the intervention group.

RELATED: Enzalutamide Improves Quality of Life in Chemo-Naive Prostate Cancer

Eighty percent of participants reported that their decision to participate in the exercise program was influenced by the clinician's referral.

"Further research is needed to determine the sustainability of the exercise program and its generalizability to other cancer populations," the authors write.

Reference

  1. Livingston, Patricia M., PhD, et al. "Effects of a clinician referral and exercise program for men who have completed active treatment for prostate cancer: A multicenter cluster randomized controlled trial (ENGAGE)." Cancer. DOI: 10.1002/cncr.29385. [epub ahead of print]. April 15, 2015.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs